BioGaia
101.10 SEK
+0.10 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.10 %
-2.88 %
-3.90 %
-1.75 %
-9.65 %
-7.50 %
+20.04 %
-0.30 %
+1,323.28 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
10.23B SEK
Turnover
23.48M SEK
Revenue
1.42B
EBIT %
29.76 %
P/E
29.05
Dividend yield-%
6.82 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
All
Webcasts
Press releases
ShowingAll content types
BioGaia AB: Delårsredogörelse januari - september 2025
BioGaia AB: Interim Management Statement January - September 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
